nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—STK10—renal artery—thoracic aortic aneurysm	0.0295	0.0943	CbGeAlD
Bosutinib—BMPR2—pulmonary artery—thoracic aortic aneurysm	0.0245	0.0782	CbGeAlD
Bosutinib—EPHA2—pulmonary artery—thoracic aortic aneurysm	0.0174	0.0556	CbGeAlD
Bosutinib—RPS6KB1—leg—thoracic aortic aneurysm	0.0127	0.0406	CbGeAlD
Bosutinib—BMPR2—artery—thoracic aortic aneurysm	0.00908	0.029	CbGeAlD
Bosutinib—SRC—artery—thoracic aortic aneurysm	0.00559	0.0179	CbGeAlD
Bosutinib—CLK3—cardiac atrium—thoracic aortic aneurysm	0.0044	0.0141	CbGeAlD
Bosutinib—EIF2AK1—cardiac atrium—thoracic aortic aneurysm	0.00426	0.0136	CbGeAlD
Bosutinib—VRK2—cardiac atrium—thoracic aortic aneurysm	0.00412	0.0132	CbGeAlD
Bosutinib—PRKCQ—spinal cord—thoracic aortic aneurysm	0.00394	0.0126	CbGeAlD
Bosutinib—WEE1—cardiac atrium—thoracic aortic aneurysm	0.0038	0.0122	CbGeAlD
Bosutinib—DMPK—cardiac atrium—thoracic aortic aneurysm	0.0038	0.0122	CbGeAlD
Bosutinib—STK25—cardiac atrium—thoracic aortic aneurysm	0.00363	0.0116	CbGeAlD
Bosutinib—PHKG1—spinal cord—thoracic aortic aneurysm	0.00362	0.0116	CbGeAlD
Bosutinib—EIF2AK1—spinal cord—thoracic aortic aneurysm	0.00358	0.0114	CbGeAlD
Bosutinib—PLK2—cardiac atrium—thoracic aortic aneurysm	0.00353	0.0113	CbGeAlD
Bosutinib—SIK3—cardiac atrium—thoracic aortic aneurysm	0.00351	0.0112	CbGeAlD
Bosutinib—VRK2—spinal cord—thoracic aortic aneurysm	0.00347	0.0111	CbGeAlD
Bosutinib—TNIK—spinal cord—thoracic aortic aneurysm	0.0034	0.0109	CbGeAlD
Bosutinib—SYK—spinal cord—thoracic aortic aneurysm	0.0034	0.0109	CbGeAlD
Bosutinib—CAMK1D—cardiac atrium—thoracic aortic aneurysm	0.00334	0.0107	CbGeAlD
Bosutinib—DMPK—spinal cord—thoracic aortic aneurysm	0.0032	0.0102	CbGeAlD
Bosutinib—FER—cardiac atrium—thoracic aortic aneurysm	0.00319	0.0102	CbGeAlD
Bosutinib—STK25—spinal cord—thoracic aortic aneurysm	0.00305	0.00975	CbGeAlD
Bosutinib—ERBB4—cardiac atrium—thoracic aortic aneurysm	0.00298	0.00953	CbGeAlD
Bosutinib—PLK2—spinal cord—thoracic aortic aneurysm	0.00297	0.00948	CbGeAlD
Bosutinib—BMPR2—cardiac atrium—thoracic aortic aneurysm	0.00286	0.00914	CbGeAlD
Bosutinib—MAP4K4—cardiac atrium—thoracic aortic aneurysm	0.00275	0.00879	CbGeAlD
Bosutinib—BCR—cardiac atrium—thoracic aortic aneurysm	0.00273	0.00873	CbGeAlD
Bosutinib—MAP3K12—cardiac atrium—thoracic aortic aneurysm	0.00271	0.00867	CbGeAlD
Bosutinib—TYRO3—spinal cord—thoracic aortic aneurysm	0.00268	0.00857	CbGeAlD
Bosutinib—FER—spinal cord—thoracic aortic aneurysm	0.00268	0.00857	CbGeAlD
Bosutinib—EPHA5—spinal cord—thoracic aortic aneurysm	0.00268	0.00857	CbGeAlD
Bosutinib—STK35—cardiac atrium—thoracic aortic aneurysm	0.00266	0.00849	CbGeAlD
Bosutinib—CSK—cardiac atrium—thoracic aortic aneurysm	0.00264	0.00844	CbGeAlD
Bosutinib—CSNK1A1—cardiac atrium—thoracic aortic aneurysm	0.00262	0.00838	CbGeAlD
Bosutinib—BTK—spinal cord—thoracic aortic aneurysm	0.00261	0.00835	CbGeAlD
Bosutinib—CLK1—cardiac atrium—thoracic aortic aneurysm	0.00261	0.00833	CbGeAlD
Bosutinib—ERBB4—spinal cord—thoracic aortic aneurysm	0.00251	0.00801	CbGeAlD
Bosutinib—SIK1—cardiac atrium—thoracic aortic aneurysm	0.00239	0.00765	CbGeAlD
Bosutinib—EPHB3—spinal cord—thoracic aortic aneurysm	0.00238	0.00762	CbGeAlD
Bosutinib—EPHA4—cardiac atrium—thoracic aortic aneurysm	0.00237	0.00757	CbGeAlD
Bosutinib—ULK3—cardiac atrium—thoracic aortic aneurysm	0.00234	0.00748	CbGeAlD
Bosutinib—MAP2K2—cardiac atrium—thoracic aortic aneurysm	0.00234	0.00748	CbGeAlD
Bosutinib—MAP4K4—spinal cord—thoracic aortic aneurysm	0.00231	0.00739	CbGeAlD
Bosutinib—MAP3K7—cardiac atrium—thoracic aortic aneurysm	0.0023	0.00735	CbGeAlD
Bosutinib—BCR—spinal cord—thoracic aortic aneurysm	0.0023	0.00734	CbGeAlD
Bosutinib—MAP3K12—spinal cord—thoracic aortic aneurysm	0.00228	0.00729	CbGeAlD
Bosutinib—TBK1—cardiac atrium—thoracic aortic aneurysm	0.00228	0.00727	CbGeAlD
Bosutinib—MAP2K1—spinal cord—thoracic aortic aneurysm	0.00223	0.00714	CbGeAlD
Bosutinib—CSK—spinal cord—thoracic aortic aneurysm	0.00222	0.00709	CbGeAlD
Bosutinib—CSNK1A1—spinal cord—thoracic aortic aneurysm	0.00221	0.00705	CbGeAlD
Bosutinib—HCK—spinal cord—thoracic aortic aneurysm	0.00219	0.007	CbGeAlD
Bosutinib—CLK1—spinal cord—thoracic aortic aneurysm	0.00219	0.007	CbGeAlD
Bosutinib—RPS6KB1—cardiac atrium—thoracic aortic aneurysm	0.00219	0.00699	CbGeAlD
Bosutinib—AXL—cardiac atrium—thoracic aortic aneurysm	0.00217	0.00692	CbGeAlD
Bosutinib—BMP2K—spinal cord—thoracic aortic aneurysm	0.00215	0.00687	CbGeAlD
Bosutinib—CAMK2G—spinal cord—thoracic aortic aneurysm	0.00215	0.00687	CbGeAlD
Bosutinib—LRRK2—spinal cord—thoracic aortic aneurysm	0.00213	0.00681	CbGeAlD
Bosutinib—SLK—cardiac atrium—thoracic aortic aneurysm	0.00209	0.00666	CbGeAlD
Bosutinib—EPHB4—cardiac atrium—thoracic aortic aneurysm	0.00207	0.00662	CbGeAlD
Bosutinib—CSNK1E—spinal cord—thoracic aortic aneurysm	0.00204	0.00653	CbGeAlD
Bosutinib—EPHA2—cardiac atrium—thoracic aortic aneurysm	0.00203	0.00649	CbGeAlD
Bosutinib—FYN—cardiac atrium—thoracic aortic aneurysm	0.00203	0.00648	CbGeAlD
Bosutinib—IRAK4—spinal cord—thoracic aortic aneurysm	0.00201	0.00643	CbGeAlD
Bosutinib—SIK1—spinal cord—thoracic aortic aneurysm	0.00201	0.00643	CbGeAlD
Bosutinib—MAP4K5—cardiac atrium—thoracic aortic aneurysm	0.00198	0.00633	CbGeAlD
Bosutinib—MAP3K3—cardiac atrium—thoracic aortic aneurysm	0.00198	0.00633	CbGeAlD
Bosutinib—ERBB3—spinal cord—thoracic aortic aneurysm	0.00197	0.0063	CbGeAlD
Bosutinib—ULK3—spinal cord—thoracic aortic aneurysm	0.00197	0.00629	CbGeAlD
Bosutinib—MAP2K2—spinal cord—thoracic aortic aneurysm	0.00197	0.00629	CbGeAlD
Bosutinib—MAP3K7—spinal cord—thoracic aortic aneurysm	0.00193	0.00618	CbGeAlD
Bosutinib—PTK2—spinal cord—thoracic aortic aneurysm	0.00191	0.00611	CbGeAlD
Bosutinib—TBK1—spinal cord—thoracic aortic aneurysm	0.00191	0.00611	CbGeAlD
Bosutinib—RPS6KB1—spinal cord—thoracic aortic aneurysm	0.00184	0.00588	CbGeAlD
Bosutinib—YES1—cardiac atrium—thoracic aortic aneurysm	0.00183	0.00585	CbGeAlD
Bosutinib—AXL—spinal cord—thoracic aortic aneurysm	0.00182	0.00582	CbGeAlD
Bosutinib—TAOK3—cardiac atrium—thoracic aortic aneurysm	0.00181	0.00577	CbGeAlD
Bosutinib—SRC—cardiac atrium—thoracic aortic aneurysm	0.00176	0.00563	CbGeAlD
Bosutinib—SLK—spinal cord—thoracic aortic aneurysm	0.00175	0.0056	CbGeAlD
Bosutinib—EPHB4—spinal cord—thoracic aortic aneurysm	0.00174	0.00556	CbGeAlD
Bosutinib—FYN—spinal cord—thoracic aortic aneurysm	0.0017	0.00545	CbGeAlD
Bosutinib—MAP3K3—spinal cord—thoracic aortic aneurysm	0.00167	0.00532	CbGeAlD
Bosutinib—MAP4K5—spinal cord—thoracic aortic aneurysm	0.00167	0.00532	CbGeAlD
Bosutinib—MAP2K5—cardiac atrium—thoracic aortic aneurysm	0.00162	0.00518	CbGeAlD
Bosutinib—CSF1R—cardiac atrium—thoracic aortic aneurysm	0.00158	0.00505	CbGeAlD
Bosutinib—YES1—spinal cord—thoracic aortic aneurysm	0.00154	0.00492	CbGeAlD
Bosutinib—TAOK3—spinal cord—thoracic aortic aneurysm	0.00152	0.00485	CbGeAlD
Bosutinib—SRC—spinal cord—thoracic aortic aneurysm	0.00148	0.00473	CbGeAlD
Bosutinib—PDGFRB—cardiac atrium—thoracic aortic aneurysm	0.0014	0.00448	CbGeAlD
Bosutinib—MAP2K5—spinal cord—thoracic aortic aneurysm	0.00136	0.00435	CbGeAlD
Bosutinib—CSF1R—spinal cord—thoracic aortic aneurysm	0.00133	0.00425	CbGeAlD
Bosutinib—ABL1—cardiac atrium—thoracic aortic aneurysm	0.00125	0.00399	CbGeAlD
Bosutinib—PDGFRB—spinal cord—thoracic aortic aneurysm	0.00118	0.00377	CbGeAlD
Bosutinib—ABL1—spinal cord—thoracic aortic aneurysm	0.00105	0.00336	CbGeAlD
Bosutinib—ABCB1—spinal cord—thoracic aortic aneurysm	0.000327	0.00104	CbGeAlD
Bosutinib—CSNK1A1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	0.000102	0.000149	CbGpPWpGaD
Bosutinib—ERBB4—Disease—ADAM10—thoracic aortic aneurysm	0.000102	0.000148	CbGpPWpGaD
Bosutinib—MAP2K2—Axon guidance—MMP2—thoracic aortic aneurysm	0.000101	0.000148	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000101	0.000147	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000101	0.000147	CbGpPWpGaD
Bosutinib—LYN—Immune System—PRKG1—thoracic aortic aneurysm	0.0001	0.000146	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—SMAD3—thoracic aortic aneurysm	0.0001	0.000146	CbGpPWpGaD
Bosutinib—HCK—Disease—TGFBR2—thoracic aortic aneurysm	0.0001	0.000146	CbGpPWpGaD
Bosutinib—ABL1—Immune System—PRKG1—thoracic aortic aneurysm	9.97e-05	0.000145	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—SMAD3—thoracic aortic aneurysm	9.97e-05	0.000145	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—ADAM17—thoracic aortic aneurysm	9.94e-05	0.000145	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—SMAD3—thoracic aortic aneurysm	9.91e-05	0.000144	CbGpPWpGaD
Bosutinib—PTK2—Axon guidance—MMP9—thoracic aortic aneurysm	9.91e-05	0.000144	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—PRKG1—thoracic aortic aneurysm	9.9e-05	0.000144	CbGpPWpGaD
Bosutinib—FYN—Immune System—PRKG1—thoracic aortic aneurysm	9.86e-05	0.000144	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—ADAM10—thoracic aortic aneurysm	9.86e-05	0.000144	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—PRKG1—thoracic aortic aneurysm	9.81e-05	0.000143	CbGpPWpGaD
Bosutinib—YES1—Axon guidance—MMP9—thoracic aortic aneurysm	9.77e-05	0.000142	CbGpPWpGaD
Bosutinib—LYN—Axon guidance—MMP2—thoracic aortic aneurysm	9.7e-05	0.000141	CbGpPWpGaD
Bosutinib—ABL1—Axon guidance—MMP2—thoracic aortic aneurysm	9.65e-05	0.00014	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—SMAD3—thoracic aortic aneurysm	9.64e-05	0.00014	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	9.62e-05	0.00014	CbGpPWpGaD
Bosutinib—FYN—Axon guidance—MMP2—thoracic aortic aneurysm	9.55e-05	0.000139	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—MMP9—thoracic aortic aneurysm	9.53e-05	0.000139	CbGpPWpGaD
Bosutinib—MAP2K1—Axon guidance—MMP2—thoracic aortic aneurysm	9.5e-05	0.000138	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	9.45e-05	0.000137	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	9.45e-05	0.000137	CbGpPWpGaD
Bosutinib—ERBB4—Disease—TGFBR2—thoracic aortic aneurysm	9.42e-05	0.000137	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—MMP2—thoracic aortic aneurysm	9.41e-05	0.000137	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—ADAM17—thoracic aortic aneurysm	9.3e-05	0.000135	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	9.3e-05	0.000135	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—MMP2—thoracic aortic aneurysm	9.28e-05	0.000135	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—ADAM17—thoracic aortic aneurysm	9.17e-05	0.000133	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	9.17e-05	0.000133	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	9.12e-05	0.000133	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—ADAM10—thoracic aortic aneurysm	8.97e-05	0.000131	CbGpPWpGaD
Bosutinib—ERBB3—Disease—ADAM10—thoracic aortic aneurysm	8.97e-05	0.000131	CbGpPWpGaD
Bosutinib—HCK—Disease—SMAD3—thoracic aortic aneurysm	8.85e-05	0.000129	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	8.83e-05	0.000129	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	8.83e-05	0.000129	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—PRKG1—thoracic aortic aneurysm	8.81e-05	0.000128	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—ADAM17—thoracic aortic aneurysm	8.69e-05	0.000126	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—PRKG1—thoracic aortic aneurysm	8.69e-05	0.000126	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—SMAD3—thoracic aortic aneurysm	8.61e-05	0.000125	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—MMP9—thoracic aortic aneurysm	8.56e-05	0.000125	CbGpPWpGaD
Bosutinib—EGFR—Immune System—PRKG1—thoracic aortic aneurysm	8.52e-05	0.000124	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—SMAD3—thoracic aortic aneurysm	8.51e-05	0.000124	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	8.51e-05	0.000124	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	8.51e-05	0.000124	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	8.51e-05	0.000124	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—ADAM17—thoracic aortic aneurysm	8.51e-05	0.000124	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—ADAM17—thoracic aortic aneurysm	8.48e-05	0.000123	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	8.36e-05	0.000122	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—SMAD3—thoracic aortic aneurysm	8.36e-05	0.000122	CbGpPWpGaD
Bosutinib—ERBB4—Disease—SMAD3—thoracic aortic aneurysm	8.33e-05	0.000121	CbGpPWpGaD
Bosutinib—ERBB3—Disease—TGFBR2—thoracic aortic aneurysm	8.3e-05	0.000121	CbGpPWpGaD
Bosutinib—LYN—Immune System—ADAM17—thoracic aortic aneurysm	8.3e-05	0.000121	CbGpPWpGaD
Bosutinib—ABL1—Immune System—ADAM17—thoracic aortic aneurysm	8.26e-05	0.00012	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—ADAM10—thoracic aortic aneurysm	8.25e-05	0.00012	CbGpPWpGaD
Bosutinib—EGFR—Axon guidance—MMP2—thoracic aortic aneurysm	8.25e-05	0.00012	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—PRKG1—thoracic aortic aneurysm	8.24e-05	0.00012	CbGpPWpGaD
Bosutinib—LCK—Immune System—PRKG1—thoracic aortic aneurysm	8.21e-05	0.00012	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—ADAM17—thoracic aortic aneurysm	8.2e-05	0.000119	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	8.2e-05	0.000119	CbGpPWpGaD
Bosutinib—FYN—Immune System—ADAM17—thoracic aortic aneurysm	8.17e-05	0.000119	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—ADAM17—thoracic aortic aneurysm	8.13e-05	0.000118	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—MMP9—thoracic aortic aneurysm	8.1e-05	0.000118	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—SMAD3—thoracic aortic aneurysm	8.07e-05	0.000117	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFBR1—thoracic aortic aneurysm	8.02e-05	0.000117	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—ADAM17—thoracic aortic aneurysm	8.02e-05	0.000117	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—ADAM17—thoracic aortic aneurysm	7.83e-05	0.000114	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFBR1—thoracic aortic aneurysm	7.83e-05	0.000114	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—PRKG1—thoracic aortic aneurysm	7.76e-05	0.000113	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	7.63e-05	0.000111	CbGpPWpGaD
Bosutinib—MAP2K2—Axon guidance—MMP9—thoracic aortic aneurysm	7.63e-05	0.000111	CbGpPWpGaD
Bosutinib—FYN—Disease—ADAM17—thoracic aortic aneurysm	7.55e-05	0.00011	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFBR1—thoracic aortic aneurysm	7.55e-05	0.00011	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—ADAM17—thoracic aortic aneurysm	7.5e-05	0.000109	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFBR1—thoracic aortic aneurysm	7.5e-05	0.000109	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—SMAD3—thoracic aortic aneurysm	7.35e-05	0.000107	CbGpPWpGaD
Bosutinib—ERBB3—Disease—SMAD3—thoracic aortic aneurysm	7.35e-05	0.000107	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—ADAM17—thoracic aortic aneurysm	7.3e-05	0.000106	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	7.3e-05	0.000106	CbGpPWpGaD
Bosutinib—LYN—Axon guidance—MMP9—thoracic aortic aneurysm	7.29e-05	0.000106	CbGpPWpGaD
Bosutinib—SRC—Immune System—PRKG1—thoracic aortic aneurysm	7.27e-05	0.000106	CbGpPWpGaD
Bosutinib—ABL1—Axon guidance—MMP9—thoracic aortic aneurysm	7.25e-05	0.000106	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—MMP2—thoracic aortic aneurysm	7.24e-05	0.000105	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	7.2e-05	0.000105	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	7.2e-05	0.000105	CbGpPWpGaD
Bosutinib—FYN—Axon guidance—MMP9—thoracic aortic aneurysm	7.18e-05	0.000104	CbGpPWpGaD
Bosutinib—MAP2K1—Axon guidance—MMP9—thoracic aortic aneurysm	7.14e-05	0.000104	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—ADAM10—thoracic aortic aneurysm	7.13e-05	0.000104	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—MMP9—thoracic aortic aneurysm	7.07e-05	0.000103	CbGpPWpGaD
Bosutinib—EGFR—Immune System—ADAM17—thoracic aortic aneurysm	7.06e-05	0.000103	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—MMP2—thoracic aortic aneurysm	7.04e-05	0.000102	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—ADAM10—thoracic aortic aneurysm	7.03e-05	0.000102	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—MMP9—thoracic aortic aneurysm	6.97e-05	0.000102	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—MMP2—thoracic aortic aneurysm	6.92e-05	0.000101	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—MMP2—thoracic aortic aneurysm	6.89e-05	0.0001	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	6.83e-05	9.94e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	6.83e-05	9.94e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—MMP2—thoracic aortic aneurysm	6.81e-05	9.92e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—ADAM17—thoracic aortic aneurysm	6.8e-05	9.9e-05	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—MMP9—thoracic aortic aneurysm	6.79e-05	9.88e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—PRKG1—thoracic aortic aneurysm	6.78e-05	9.87e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—MMP2—thoracic aortic aneurysm	6.78e-05	9.86e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	6.77e-05	9.85e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—SMAD3—thoracic aortic aneurysm	6.75e-05	9.83e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—PRKG1—thoracic aortic aneurysm	6.62e-05	9.63e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	6.6e-05	9.6e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	6.52e-05	9.49e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—ADAM10—thoracic aortic aneurysm	6.52e-05	9.49e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFBR1—thoracic aortic aneurysm	6.52e-05	9.49e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—ADAM17—thoracic aortic aneurysm	6.52e-05	9.49e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	6.5e-05	9.46e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—PRKG1—thoracic aortic aneurysm	6.48e-05	9.43e-05	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—MMP9—thoracic aortic aneurysm	6.43e-05	9.36e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—ADAM17—thoracic aortic aneurysm	6.43e-05	9.36e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	6.43e-05	9.36e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—PRKG1—thoracic aortic aneurysm	6.38e-05	9.28e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—PRKG1—thoracic aortic aneurysm	6.34e-05	9.23e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—ADAM10—thoracic aortic aneurysm	6.28e-05	9.15e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—ADAM17—thoracic aortic aneurysm	6.28e-05	9.14e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFBR1—thoracic aortic aneurysm	6.28e-05	9.14e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	6.26e-05	9.11e-05	CbGpPWpGaD
Bosutinib—EGFR—Axon guidance—MMP9—thoracic aortic aneurysm	6.2e-05	9.02e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—ADAM10—thoracic aortic aneurysm	6.15e-05	8.95e-05	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—MMP9—thoracic aortic aneurysm	6.14e-05	8.93e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	6.03e-05	8.78e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	6.03e-05	8.78e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—ADAM17—thoracic aortic aneurysm	6.02e-05	8.77e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—ADAM10—thoracic aortic aneurysm	6e-05	8.73e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—MMP2—thoracic aortic aneurysm	5.89e-05	8.57e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—MMP9—thoracic aortic aneurysm	5.88e-05	8.57e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—SMAD3—thoracic aortic aneurysm	5.83e-05	8.49e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	5.81e-05	8.46e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—ADAM10—thoracic aortic aneurysm	5.78e-05	8.42e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—ADAM10—thoracic aortic aneurysm	5.75e-05	8.37e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—SMAD3—thoracic aortic aneurysm	5.75e-05	8.37e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFBR2—thoracic aortic aneurysm	5.69e-05	8.28e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—ADAM17—thoracic aortic aneurysm	5.62e-05	8.18e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	5.62e-05	8.18e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—ADAM10—thoracic aortic aneurysm	5.59e-05	8.14e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—ADAM17—thoracic aortic aneurysm	5.56e-05	8.09e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFBR1—thoracic aortic aneurysm	5.56e-05	8.09e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFBR2—thoracic aortic aneurysm	5.55e-05	8.08e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	5.54e-05	8.06e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	5.52e-05	8.03e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PRKG1—thoracic aortic aneurysm	5.51e-05	8.02e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—ADAM17—thoracic aortic aneurysm	5.48e-05	7.98e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	5.48e-05	7.98e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—MMP9—thoracic aortic aneurysm	5.44e-05	7.92e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—ADAM17—thoracic aortic aneurysm	5.37e-05	7.81e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	5.37e-05	7.81e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFBR2—thoracic aortic aneurysm	5.35e-05	7.79e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	5.34e-05	7.77e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—SMAD3—thoracic aortic aneurysm	5.34e-05	7.77e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFBR2—thoracic aortic aneurysm	5.32e-05	7.75e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PRKG1—thoracic aortic aneurysm	5.31e-05	7.73e-05	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—MMP9—thoracic aortic aneurysm	5.29e-05	7.7e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—ADAM17—thoracic aortic aneurysm	5.28e-05	7.69e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	5.28e-05	7.69e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—ADAM17—thoracic aortic aneurysm	5.26e-05	7.65e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	5.26e-05	7.65e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	5.23e-05	7.62e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—MMP9—thoracic aortic aneurysm	5.2e-05	7.57e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—MMP9—thoracic aortic aneurysm	5.18e-05	7.53e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	5.18e-05	7.53e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—MMP9—thoracic aortic aneurysm	5.14e-05	7.49e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—SMAD3—thoracic aortic aneurysm	5.14e-05	7.49e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—MMP9—thoracic aortic aneurysm	5.12e-05	7.45e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	5.1e-05	7.43e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—MMP9—thoracic aortic aneurysm	5.09e-05	7.41e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—SMAD3—thoracic aortic aneurysm	5.03e-05	7.32e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—MMP2—thoracic aortic aneurysm	5.02e-05	7.31e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—ADAM10—thoracic aortic aneurysm	5e-05	7.27e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—ADAM10—thoracic aortic aneurysm	4.93e-05	7.17e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—SMAD3—thoracic aortic aneurysm	4.91e-05	7.15e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	4.84e-05	7.05e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—ADAM10—thoracic aortic aneurysm	4.81e-05	7.01e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—SMAD3—thoracic aortic aneurysm	4.73e-05	6.89e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—SMAD3—thoracic aortic aneurysm	4.71e-05	6.85e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PRKG1—thoracic aortic aneurysm	4.7e-05	6.84e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFBR2—thoracic aortic aneurysm	4.62e-05	6.73e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SMAD3—thoracic aortic aneurysm	4.58e-05	6.66e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	4.56e-05	6.64e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—ADAM17—thoracic aortic aneurysm	4.56e-05	6.64e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	4.56e-05	6.63e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	4.52e-05	6.57e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFBR2—thoracic aortic aneurysm	4.45e-05	6.48e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—MMP9—thoracic aortic aneurysm	4.42e-05	6.44e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ADAM17—thoracic aortic aneurysm	4.4e-05	6.4e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	4.4e-05	6.4e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—MMP9—thoracic aortic aneurysm	4.37e-05	6.37e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—ADAM10—thoracic aortic aneurysm	4.31e-05	6.27e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—MMP9—thoracic aortic aneurysm	4.29e-05	6.25e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—MMP9—thoracic aortic aneurysm	4.29e-05	6.25e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	4.28e-05	6.23e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—ADAM10—thoracic aortic aneurysm	4.26e-05	6.2e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—ADAM10—thoracic aortic aneurysm	4.2e-05	6.12e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—MMP9—thoracic aortic aneurysm	4.15e-05	6.03e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—ADAM10—thoracic aortic aneurysm	4.11e-05	5.99e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—SMAD3—thoracic aortic aneurysm	4.09e-05	5.95e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—ADAM10—thoracic aortic aneurysm	4.05e-05	5.89e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SMAD3—thoracic aortic aneurysm	4.03e-05	5.87e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—ADAM10—thoracic aortic aneurysm	4.03e-05	5.86e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.98e-05	5.8e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFBR2—thoracic aortic aneurysm	3.94e-05	5.74e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—SMAD3—thoracic aortic aneurysm	3.94e-05	5.74e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ADAM17—thoracic aortic aneurysm	3.89e-05	5.67e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	3.89e-05	5.67e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.89e-05	5.66e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.81e-05	5.54e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—MMP9—thoracic aortic aneurysm	3.77e-05	5.49e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.75e-05	5.45e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.73e-05	5.42e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SMAD3—thoracic aortic aneurysm	3.52e-05	5.13e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—ADAM10—thoracic aortic aneurysm	3.5e-05	5.09e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—SMAD3—thoracic aortic aneurysm	3.49e-05	5.08e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—MMP9—thoracic aortic aneurysm	3.47e-05	5.05e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SMAD3—thoracic aortic aneurysm	3.44e-05	5.01e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—ADAM10—thoracic aortic aneurysm	3.37e-05	4.91e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SMAD3—thoracic aortic aneurysm	3.37e-05	4.9e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SMAD3—thoracic aortic aneurysm	3.31e-05	4.82e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SMAD3—thoracic aortic aneurysm	3.3e-05	4.8e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.24e-05	4.71e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	3.12e-05	4.54e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—MMP9—thoracic aortic aneurysm	3e-05	4.36e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—ADAM10—thoracic aortic aneurysm	2.98e-05	4.34e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.95e-05	4.3e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SMAD3—thoracic aortic aneurysm	2.86e-05	4.17e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.85e-05	4.14e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	2.76e-05	4.02e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SMAD3—thoracic aortic aneurysm	2.76e-05	4.02e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.74e-05	3.99e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.74e-05	3.99e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.64e-05	3.85e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SMAD3—thoracic aortic aneurysm	2.44e-05	3.56e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.35e-05	3.42e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.32e-05	3.38e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.2e-05	3.2e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.07e-05	3.02e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.81e-05	2.64e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.77e-05	2.57e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.73e-05	2.52e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.7e-05	2.48e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.69e-05	2.47e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.47e-05	2.14e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.42e-05	2.06e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—thoracic aortic aneurysm	1.26e-05	1.83e-05	CbGpPWpGaD
